A renewed focus on medication adherence

11/26/2012 | Forbes

Drugmakers lose approximately $188 billion yearly as patients fail to take prescribed treatments, according to the consultant Capgemini. "We need serious rethinking about what happens when medication is dispensed," said Kevin Volpp of the University of Pennsylvania's Center for Health Incentives and Behavioral Economics. Researchers and drug companies are experimenting with new approaches to boost adherence.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX